Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
728.53M | 511.02M | 515.95M | 435.59M | 312.07M | Gross Profit |
57.77M | 3.68M | 33.64M | 21.92M | 13.34M | EBIT |
34.03M | -30.15M | 11.66M | -9.01M | -12.61M | EBITDA |
140.78M | 86.95M | 90.86M | 67.06M | 49.93M | Net Income Common Stockholders |
22.22M | -21.96M | 12.13M | 3.74M | -15.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
33.49M | 27.31M | 17.26M | 16.78M | 13.51M | Total Assets |
597.27M | 567.11M | 471.06M | 389.74M | 362.79M | Total Debt |
186.66M | 213.00M | 182.16M | 114.27M | 100.29M | Net Debt |
158.20M | 185.69M | 164.91M | 97.48M | 86.79M | Total Liabilities |
340.65M | 332.72M | 266.95M | 197.76M | 174.55M | Stockholders Equity |
256.63M | 234.41M | 204.13M | 192.00M | 188.26M |
Cash Flow | Free Cash Flow | |||
88.47M | 38.04M | 32.85M | 17.05M | 27.22M | Operating Cash Flow |
102.33M | 79.20M | 75.68M | 50.32M | 70.53M | Investing Cash Flow |
-17.97M | -44.12M | -41.26M | -24.36M | -38.46M | Financing Cash Flow |
-83.22M | -25.02M | -33.95M | -22.68M | -61.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$48.97M | 1.49 | 12.40% | ― | 62.06% | ― | |
71 Outperform | $60.11B | 6.18 | 14.62% | 7.58% | 1.21% | 2.15% | |
70 Outperform | HK$16.17B | 7.02 | 18.95% | 6.96% | 4.58% | 18.73% | |
68 Neutral | HK$3.28B | 6.45 | 9.70% | 9.08% | 2.68% | 8.49% | |
65 Neutral | $2.22B | 7.72 | 4.28% | 9.12% | 2.03% | -48.30% | |
64 Neutral | $4.25B | 11.69 | 5.23% | 249.83% | 4.04% | -9.46% | |
33 Underperform | €192.18M | ― | ― | -15.39% | 19.69% |